Circulating tumor-reactive CD8+T cells in melanoma patients contain a CD45RA+CCR7-effector subset exerting ex vivo tumor-specific cytolytic activity

Cancer Research

Volumn 62, Issue 6, 2002, Pages 1743-1750

  Valmori, Danila ^a   Scheibenbogen, Carmen ^b   Dutoit, Valerie ^a   Nagorsen, Dirk ^b   Asemissen, Anne Marie ^b   Rubio Godoy, Verena ^a   Rimoldi, Donata ^c   Guillaume, Philippe ^c   Romero, Pedro ^a   Schadendorf, Dirk ^d   Lipp, Martin ^e   Dietrich, Pierre Yves ^f   Thiel, Eckhard ^b   Cerottini, Jean Charles ^a,c   Lienard, Danielle ^a   Keilholz, Ulrich ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^f UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CANCER VACCINE; CD45 ANTIGEN; CD8 ANTIGEN; CISPLATIN; CYTOKINE; DACARBAZINE; FOTEMUSTINE; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; INTERLEUKIN 7; MELANOMA VACCINE; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; T LYMPHOCYTE RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CYTOLYSIS; EFFECTOR CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TARGET CELL; TUMOR CELL; VACCINATION;

ANTIGENS, CD45; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HLA-A2 ANTIGEN; HUMANS; LYMPHOCYTE ACTIVATION; MELANOMA; MONOPHENOL MONOOXYGENASE; RECEPTORS, CHEMOKINE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 0037085937     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens
2. Human tumor antigens recognized by T lymphocytes
3. High frequencies of naive Melan-A/MART-l-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals
4. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
5. Naturally occurring HLA-A2 restricted CD8+ T cell response to the cancer testis antigen NY-ESO-l in melanoma patients
6. Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: A pilot study
7. High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma
8. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry
9. Flow cytometric determination of intracellular or secreted IFNγ, for the quantification of antigen reactive T cells
10. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
11. CCR7 expression and memory T cell diversity in humans
12. Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376
13. Phenotypic analysis of antigen-specific T lymphocytes
14. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins
15. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes
16. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-I immunodominant peptide analogues
17. Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset
18. T-cell repertoire diversity and clonal expansions in normal and clinical samples
19. An experimentally validated panel of subfamily-specific oligonucleotide primers (V α 1-w29/V β 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction
20. Immunophenotyping of melanomas for tyrosinase: Implications for vaccine development
21. Production of recombinant MART-I proteins and specific antiMART-I polyclonal and monoclonal antibodies: Use in the characterization of the human melanoma antigen MART-I
22. Reliability of PCR-based detection of occult tumour cells: Lessons from real-time RT-PCR
23. Spontaneous T cell responses to melanoma differentiation antigens from melanoma patients and healthy subjects
24. Melanoma patients respond to a CTL-defined self peptide with diverse and nonoverlapping TCR repertoires
25. Tetramer-guided analysis of TCR β-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients
26. Phenotypic and functional separation of memory and effector human CD8+ T cells
27. Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division
28. High frequency of autologous anti-melanoma CTL directed against an antigen generated by a point mutation in a new helicase gene
29. High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival
30. Skewed maturation of memory HIV-specific CD8 T lymphocytes
31. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
32. Interconversion of CD45R subsets of CD4 T cells in vivo
33. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo